Prime Medicine (PRME) Amortizatization of Intangibles (2021 - 2025)
Prime Medicine filings provide 5 years of Amortizatization of Intangibles readings, the most recent being $2.6 million for Q4 2025.
- On a quarterly basis, Amortizatization of Intangibles rose 17.89% to $2.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.7 million, a 21.51% decrease, with the full-year FY2025 number at $9.7 million, down 21.51% from a year prior.
- Amortizatization of Intangibles hit $2.6 million in Q4 2025 for Prime Medicine, up from $2.3 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $4.6 million in Q2 2024 to a low of -$193000.0 in Q1 2022.
- Median Amortizatization of Intangibles over the past 5 years was $2.3 million (2025), compared with a mean of $2.1 million.
- Biggest five-year swings in Amortizatization of Intangibles: plummeted 74.69% in 2022 and later skyrocketed 6301.79% in 2023.
- Prime Medicine's Amortizatization of Intangibles stood at $1.4 million in 2021, then plummeted by 74.69% to $350000.0 in 2022, then surged by 856.57% to $3.3 million in 2023, then tumbled by 34.05% to $2.2 million in 2024, then rose by 17.89% to $2.6 million in 2025.
- The last three reported values for Amortizatization of Intangibles were $2.6 million (Q4 2025), $2.3 million (Q3 2025), and $2.3 million (Q2 2025) per Business Quant data.